Triple Negative BC - Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer

This study will test the theory that therapy designed for each individual's tumor will improve outcomes over standard of care in a population that needs a better standard.

See detailed information including eligibility.

03/2014
12/2016
NCT02101385
Cancer, Adult Breast Cancer